Physician profile
Anil Purohit
NPI 1255541835
$44,776.09
in general payments reported to CMS, 2019-2025
31 companies · $9,454 in 2025
The $9,454 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,936 · 2020: $2,408 · 2021: $1,757 · 2022: $1,916 · 2023: $8,600 · 2024: $13K · 2025: $9,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $9,418 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,976 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,800 · Consulting Fee: $1,600 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,894.59 |
| Food and Beverage | $9,418.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,976.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,800.00 |
| Consulting Fee | $1,600.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $20,043.69 | 2019-2025 | Selectra, Solia, Edora 8 Dr-T |
| Boston Scientific Corporation | $7,978.96 | 2019-2025 | General - Therapies, Watchman Flx, General - Tachy |
| Medtronic, INC. | $5,758.43 | 2021-2025 | Micra, Pulseselect, Selectsecure |
| Medtronic Vascular, INC. | $4,366.13 | 2019-2020 | |
| Abbott Laboratories | $3,044.14 | 2019-2025 | Ensite, Aveir, Confirm Rx |
| Cardiofocus, INC. | $776.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $651.45 | 2019-2024 | Xarelto |
| Pfizer INC. | $373.03 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $279.90 | 2019-2024 | |
| Amgen INC. | $208.08 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $175.05 | 2019-2024 | Eliquis, Camzyos |
| Penumbra, INC. | $172.38 | 2022-2025 | Penumbra System |
| Inari Medical, INC. | $167.00 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $119.33 | 2019-2023 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $103.09 | 2019-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $96.81 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Merck Sharp & Dohme LLC | $93.51 | 2022-2025 | Verquvo |
| Akcea Therapeutics, INC. | $52.33 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.33 | 2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.09 | 2023-2024 | Jardiance |
| Lundbeck LLC | $35.74 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.19 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $29.33 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.26 | 2019-2023 | Evkeeza |
| Astellas Pharma US INC | $26.23 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.43 | 2023 | Arcalyst |
| Altathera Pharmaceuticals LLC | $14.55 | 2022 | |
| Kestra Medical Technology Services, INC. | $14.29 | 2023 | Assure Wcd |
| Esperion Therapeutics, INC. | $13.67 | 2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $13.24 | 2024 | Arcalyst |
| Novo Nordisk INC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Purohit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.